Australia markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
110.01+0.72 (+0.66%)
At close: 04:00PM EDT
105.45 -4.56 (-4.15%)
After hours: 04:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.93B
Enterprise value 10.90B
Trailing P/E 22.78
Forward P/E 5.86
PEG ratio (5-yr expected) 0.83
Price/sales (ttm)1.98
Price/book (mrq)1.88
Enterprise value/revenue 2.84
Enterprise value/EBITDA 9.34

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 3-21.19%
S&P500 52-week change 322.38%
52-week high 3146.70
52-week low 3103.01
50-day moving average 3117.04
200-day moving average 3125.17

Share statistics

Avg vol (3-month) 3622.37k
Avg vol (10-day) 3621.21k
Shares outstanding 563.04M
Implied shares outstanding 662.35M
Float 861.23M
% held by insiders 12.79%
% held by institutions 196.76%
Shares short (15 Apr 2024) 43.7M
Short ratio (15 Apr 2024) 45.44
Short % of float (15 Apr 2024) 47.73%
Short % of shares outstanding (15 Apr 2024) 45.87%
Shares short (prior month 15 Mar 2024) 42.77M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.61%
Operating margin (ttm)11.66%

Management effectiveness

Return on assets (ttm)4.07%
Return on equity (ttm)9.41%

Income statement

Revenue (ttm)3.84B
Revenue per share (ttm)60.96
Quarterly revenue growth (yoy)1.00%
Gross profit (ttm)N/A
EBITDA 1.37B
Net income avi to common (ttm)330.79M
Diluted EPS (ttm)4.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.82B
Total cash per share (mrq)28.92
Total debt (mrq)5.79B
Total debt/equity (mrq)156.50%
Current ratio (mrq)2.27
Book value per share (mrq)58.65

Cash flow statement

Operating cash flow (ttm)1.04B
Levered free cash flow (ttm)1.04B